Report cover image

Manga Market

Publisher Grand View Research
Published Jan 09, 2026
Length 150 Pages
SKU # GV20873136

Description

Manga Market Summary

The global manga market size was estimated at USD 10,193.3 million in 2025 and is projected to reach USD 43,856.1 million by 2033, growing at a CAGR of 20.5% from 2026 to 2033. The market growth is driven by the surging adoption of digital platforms, including e-books and streaming apps, as well as the explosive demand for anime adaptations and cross-media expansions.

In addition, rising social media engagement, growing proliferation of e-commerce, and diverse genre appeal spanning romance, fantasy, and sci-fi that attracts broader demographics amid cultural exports are other crucial factors driving the market growth. The growing popularity of webtoons, particularly in South Korea and China, is having a significant impact on the manga sector. Webtoons, which are typically published on digital platforms in a vertical scroll format, cater to the preferences of mobile-first readers. As the demand for webtoons continues to rise, many manga publishers are adapting their works to this format, either to expand their existing portfolios or tap into the expanding webtoon audience. With webtoons gaining traction worldwide, they are presenting new opportunities for manga creators and publishers to reach a broader and more diverse readership, further shaping the future of the manga industry.

The demand for a wider variety of genres within the manga industry is growing as readers increasingly seek stories that transcend traditional action and fantasy. Niche genres such as slice-of-life, romance, LGBTQ+, and horror are gaining popularity, catering to a broad range of tastes and demographics. Publishers are responding to this shift by diversifying their portfolios, creating manga that resonates with underrepresented audiences. This trend is contributing to the growth of the manga sector by attracting new readers and offering more inclusive and varied storytelling.

The role of manga as an educational tool is becoming increasingly important, especially in Japan and other parts of Asia. Educational manga, which integrates subjects such as history, science, and economics, is gaining recognition among students and educators for its ability to present complex topics in an engaging and accessible format. This genre’s use in classrooms and study programs highlights manga's growing influence in modern education, which is expected to further drive the market expansion in the coming years.

The increasing demand for manga adaptations across various media formats, including anime, video games, and live-action movies, is a key driver of the growth within the manga industry. Successful manga series such as Demon Slayer and Attack on Titan have demonstrated the potential for adaptations to broaden their reach, leading to significant increases in manga sales and audience engagement. Publishers and creators are actively exploring partnerships with anime studios and gaming companies to create cross-media content that enhances the visibility of manga. This cross-platform approach is helping to drive revenue across multiple entertainment channels, reinforcing the interconnected nature of the manga industry.

The rise of digital manga platforms is also reshaping how readers engage with the manga industry. Digital distribution offers readers the convenience of accessing manga anywhere and anytime, contributing to an increase in global readership. Digital platforms are making it easier for publishers to reach international audiences, expanding the accessibility of manga beyond traditional print formats. This shift is helping the manga industry grow its international presence and reach a new generation of readers who prefer digital content.

The increasing integration of manga into pop culture is influencing the broader entertainment industry. Manga’s influence on fashion, music, and social media is creating a deeper connection with younger audiences, particularly those in Generation Z. This cultural crossover is driving a surge in the demand for manga-related content, leading to greater investments from publishers and entertainment companies. Manga's prominent role in shaping modern pop culture is likely to expand its influence on global entertainment trends, further solidifying its position within the industry.

Global Manga Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest technology trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global manga market report based on content, distribution channel, genre, gender, audience, and region:
  • Content Outlook (Revenue, USD Million, 2021 - 2033)
  • Printed
  • Digital
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Online
  • Offline
  • Genre Outlook (Revenue, USD Million, 2021 - 2033)
  • Action and Adventure
  • Sci-Fi and Fantasy
  • Sports
  • Romance and Drama
  • Others
  • Gender Outlook (Revenue, USD Million, 2021 - 2033)
  • Male
  • Female
  • Audience Outlook (Revenue, USD Million, 2021 - 2033)
  • Children and Kids
  • Teenagers
  • Adults
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

150 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Treatment
1.2.2. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Glioblastoma Multiforme Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Glioblastoma Multiforme Treatment Market: Treatment Business Analysis
4.1. Treatment Market Share, 2025 & 2033
4.2. Treatment Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2021 to 2033 (USD Million)
4.4. Surgery
4.4.1. Surgery Market, 2021 - 2033 (USD Million)
4.5. Radiation Therapy
4.5.1. Radiation Therapy Market, 2021 - 2033 (USD Million)
4.6. Chemotherapy
4.6.1. Chemotherapy Market, 2021 - 2033 (USD Million)
4.6.2. Temozolomide
4.6.2.1. Temozolomide Market, 2021 - 2033 (USD Million)
4.6.3. Lomustine
4.6.3.1. Lomustine Market, 2021 - 2033 (USD Million)
4.6.4. Carmustine Wafers
4.6.4.1. Carmustine Wafers Market, 2021 - 2033 (USD Million)
4.6.5. Other
4.6.5.1. Other Market, 2021 - 2033 (USD Million)
4.7. Targeted Therapy (Bevacizumab)
4.7.1. Targeted Therapy (Bevacizumab) Market, 2021 - 2033 (USD Million)
4.8. Tumor Treating Field (TTF) Therapy
4.8.1. Tumor Treating Field (TTF) Therapy Market, 2021 - 2033 (USD Million)
Chapter 5. Glioblastoma Multiforme Treatment Market: End Use Business Analysis
5.1. End Use Market Share, 2025 & 2033
5.2. End Use Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals Market, 2021 - 2033 (USD Million)
5.5. Clinics / Outpatient Centers
5.5.1. Clinics / Outpatient Centers Market, 2021 - 2033 (USD Million)
5.6. Ambulatory Surgical Centers
5.6.1. Ambulatory Surgical Centers Market, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Glioblastoma Multiforme Treatment Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America Glioblastoma Multiforme Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. U.S. Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Europe Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. Uk Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Japan Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. China Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait Glioblastoma Multiforme Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Merck & Co., Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Treatment Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Amgen, Inc.
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Treatment Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. F. Hoffmann-La Roche Ltd.
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Treatment Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. Pfizer Inc.
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Treatment Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. Teva Pharmaceutical Industries Ltd.
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Treatment Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. Sun Pharmaceutical Industries Ltd.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Treatment Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. Arbor Pharmaceuticals, LLC
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Treatment Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. Amneal Pharmaceuticals
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Treatment Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Karyopharm Therapeutics, Inc.
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Treatment Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. Sumitomo Dainippon Pharma Oncology, Inc. (Boston Biomedical, Inc.)
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Treatment Benchmarking
7.5.10.4. Strategic Initiatives

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us